nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS1—esophageal cancer	0.299	0.636	CbGaD
Tolmetin—MPO—Carboplatin—esophageal cancer	0.179	0.436	CbGbCtD
Tolmetin—PTGS2—esophageal cancer	0.171	0.364	CbGaD
Tolmetin—MPO—Cisplatin—esophageal cancer	0.153	0.373	CbGbCtD
Tolmetin—PTGS2—Cisplatin—esophageal cancer	0.0527	0.129	CbGbCtD
Tolmetin—SLC22A6—Methotrexate—esophageal cancer	0.0253	0.0619	CbGbCtD
Tolmetin—TDO2—lung—esophageal cancer	0.00199	0.112	CbGeAlD
Tolmetin—CXCL8—bronchus—esophageal cancer	0.0017	0.0956	CbGeAlD
Tolmetin—CXCL8—smooth muscle tissue—esophageal cancer	0.00166	0.0935	CbGeAlD
Tolmetin—CXCL8—trachea—esophageal cancer	0.00153	0.0858	CbGeAlD
Tolmetin—TDO2—lymph node—esophageal cancer	0.00136	0.0766	CbGeAlD
Tolmetin—Indomethacin—GLO1—esophageal cancer	0.00124	0.211	CrCbGaD
Tolmetin—CXCL8—lung—esophageal cancer	0.0011	0.0617	CbGeAlD
Tolmetin—MPO—epithelium—esophageal cancer	0.00101	0.0568	CbGeAlD
Tolmetin—MPO—digestive system—esophageal cancer	0.000769	0.0432	CbGeAlD
Tolmetin—CXCL8—lymph node—esophageal cancer	0.000751	0.0422	CbGeAlD
Tolmetin—MPO—lung—esophageal cancer	0.000642	0.0361	CbGeAlD
Tolmetin—Zolpidem—PTGS1—esophageal cancer	0.000515	0.0877	CrCbGaD
Tolmetin—PTGS1—epithelium—esophageal cancer	0.000479	0.0269	CbGeAlD
Tolmetin—Ketorolac—PTGS1—esophageal cancer	0.000478	0.0815	CrCbGaD
Tolmetin—PTGS1—smooth muscle tissue—esophageal cancer	0.000462	0.0259	CbGeAlD
Tolmetin—Bromfenac—PTGS1—esophageal cancer	0.000459	0.0782	CrCbGaD
Tolmetin—PTGS2—epithelium—esophageal cancer	0.000458	0.0257	CbGeAlD
Tolmetin—PTGS2—bronchus—esophageal cancer	0.000451	0.0253	CbGeAlD
Tolmetin—PTGS2—smooth muscle tissue—esophageal cancer	0.000441	0.0248	CbGeAlD
Tolmetin—MPO—lymph node—esophageal cancer	0.000439	0.0247	CbGeAlD
Tolmetin—PTGS1—trachea—esophageal cancer	0.000424	0.0238	CbGeAlD
Tolmetin—PTGS2—trachea—esophageal cancer	0.000405	0.0228	CbGeAlD
Tolmetin—Lumiracoxib—PTGS1—esophageal cancer	0.00039	0.0665	CrCbGaD
Tolmetin—PTGS1—digestive system—esophageal cancer	0.000365	0.0205	CbGeAlD
Tolmetin—Fenbufen—PTGS1—esophageal cancer	0.000355	0.0605	CrCbGaD
Tolmetin—PTGS2—digestive system—esophageal cancer	0.000349	0.0196	CbGeAlD
Tolmetin—Body temperature increased—Carboplatin—esophageal cancer	0.000319	0.0289	CcSEcCtD
Tolmetin—PTGS1—lung—esophageal cancer	0.000305	0.0171	CbGeAlD
Tolmetin—Suprofen—PTGS1—esophageal cancer	0.000296	0.0504	CrCbGaD
Tolmetin—PTGS2—lung—esophageal cancer	0.000291	0.0164	CbGeAlD
Tolmetin—Proteinuria—Capecitabine—esophageal cancer	0.000279	0.0252	CcSEcCtD
Tolmetin—Protein urine present—Capecitabine—esophageal cancer	0.000275	0.0248	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—esophageal cancer	0.000273	0.0466	CrCbGaD
Tolmetin—Aminohippurate—ABCC2—esophageal cancer	0.000271	0.0461	CrCbGaD
Tolmetin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000267	0.0241	CcSEcCtD
Tolmetin—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000266	0.024	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—esophageal cancer	0.000262	0.0447	CrCbGaD
Tolmetin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000249	0.0225	CcSEcCtD
Tolmetin—Indomethacin—ABCC2—esophageal cancer	0.000248	0.0423	CrCbGaD
Tolmetin—Blood pressure increased—Capecitabine—esophageal cancer	0.000245	0.0221	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000241	0.0218	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—esophageal cancer	0.000223	0.038	CrCbGaD
Tolmetin—PTGS1—lymph node—esophageal cancer	0.000208	0.0117	CbGeAlD
Tolmetin—Proteinuria—Methotrexate—esophageal cancer	0.000208	0.0188	CcSEcCtD
Tolmetin—Protein urine present—Methotrexate—esophageal cancer	0.000205	0.0185	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—esophageal cancer	0.000203	0.0346	CrCbGaD
Tolmetin—Abdominal discomfort—Cisplatin—esophageal cancer	0.0002	0.0181	CcSEcCtD
Tolmetin—PTGS2—lymph node—esophageal cancer	0.000199	0.0112	CbGeAlD
Tolmetin—Vascular purpura—Capecitabine—esophageal cancer	0.000199	0.018	CcSEcCtD
Tolmetin—Glossitis—Methotrexate—esophageal cancer	0.000198	0.0179	CcSEcCtD
Tolmetin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000197	0.0178	CcSEcCtD
Tolmetin—Indomethacin—PTGS1—esophageal cancer	0.000188	0.032	CrCbGaD
Tolmetin—Purpura—Capecitabine—esophageal cancer	0.000184	0.0167	CcSEcCtD
Tolmetin—Renal failure—Cisplatin—esophageal cancer	0.000183	0.0165	CcSEcCtD
Tolmetin—Stomatitis—Cisplatin—esophageal cancer	0.000181	0.0164	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000178	0.0161	CcSEcCtD
Tolmetin—Suprofen—PTGS2—esophageal cancer	0.000169	0.0288	CrCbGaD
Tolmetin—Visual impairment—Cisplatin—esophageal cancer	0.000161	0.0145	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00016	0.0145	CcSEcCtD
Tolmetin—Gastritis—Capecitabine—esophageal cancer	0.000157	0.0142	CcSEcCtD
Tolmetin—Tinnitus—Cisplatin—esophageal cancer	0.000156	0.0141	CcSEcCtD
Tolmetin—Lymphadenopathy—Methotrexate—esophageal cancer	0.000155	0.014	CcSEcCtD
Tolmetin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000147	0.0133	CcSEcCtD
Tolmetin—Dysuria—Capecitabine—esophageal cancer	0.000144	0.013	CcSEcCtD
Tolmetin—Flatulence—Cisplatin—esophageal cancer	0.000143	0.0129	CcSEcCtD
Tolmetin—Weight increased—Capecitabine—esophageal cancer	0.00014	0.0126	CcSEcCtD
Tolmetin—Visual disturbance—Methotrexate—esophageal cancer	0.00014	0.0126	CcSEcCtD
Tolmetin—Weight decreased—Capecitabine—esophageal cancer	0.000139	0.0126	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000137	0.0124	CcSEcCtD
Tolmetin—Renal failure—Capecitabine—esophageal cancer	0.000135	0.0122	CcSEcCtD
Tolmetin—Stomatitis—Capecitabine—esophageal cancer	0.000134	0.0121	CcSEcCtD
Tolmetin—Urinary tract infection—Capecitabine—esophageal cancer	0.000133	0.012	CcSEcCtD
Tolmetin—Haematuria—Capecitabine—esophageal cancer	0.000131	0.0118	CcSEcCtD
Tolmetin—Epistaxis—Capecitabine—esophageal cancer	0.000129	0.0117	CcSEcCtD
Tolmetin—Agranulocytosis—Capecitabine—esophageal cancer	0.000128	0.0116	CcSEcCtD
Tolmetin—Hepatitis—Capecitabine—esophageal cancer	0.000123	0.0111	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000119	0.0108	CcSEcCtD
Tolmetin—Oedema—Cisplatin—esophageal cancer	0.000119	0.0107	CcSEcCtD
Tolmetin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000119	0.0107	CcSEcCtD
Tolmetin—Visual impairment—Capecitabine—esophageal cancer	0.000119	0.0107	CcSEcCtD
Tolmetin—Erythema multiforme—Capecitabine—esophageal cancer	0.000116	0.0105	CcSEcCtD
Tolmetin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000116	0.0105	CcSEcCtD
Tolmetin—Tinnitus—Capecitabine—esophageal cancer	0.000115	0.0104	CcSEcCtD
Tolmetin—Abdominal discomfort—Methotrexate—esophageal cancer	0.00011	0.00991	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—esophageal cancer	0.000107	0.0183	CrCbGaD
Tolmetin—Dysuria—Methotrexate—esophageal cancer	0.000107	0.00967	CcSEcCtD
Tolmetin—Flatulence—Capecitabine—esophageal cancer	0.000106	0.00953	CcSEcCtD
Tolmetin—Drowsiness—Methotrexate—esophageal cancer	0.000102	0.00922	CcSEcCtD
Tolmetin—Renal failure—Methotrexate—esophageal cancer	0.0001	0.00906	CcSEcCtD
Tolmetin—Aminohippurate—ABCB1—esophageal cancer	9.96e-05	0.017	CrCbGaD
Tolmetin—Stomatitis—Methotrexate—esophageal cancer	9.94e-05	0.00898	CcSEcCtD
Tolmetin—Haematuria—Methotrexate—esophageal cancer	9.73e-05	0.00879	CcSEcCtD
Tolmetin—Epistaxis—Methotrexate—esophageal cancer	9.62e-05	0.00869	CcSEcCtD
Tolmetin—Agranulocytosis—Methotrexate—esophageal cancer	9.52e-05	0.0086	CcSEcCtD
Tolmetin—Body temperature increased—Cisplatin—esophageal cancer	9.37e-05	0.00847	CcSEcCtD
Tolmetin—Hepatitis—Methotrexate—esophageal cancer	9.16e-05	0.00827	CcSEcCtD
Tolmetin—Indomethacin—ABCB1—esophageal cancer	9.14e-05	0.0156	CrCbGaD
Tolmetin—Chest pain—Capecitabine—esophageal cancer	9.12e-05	0.00824	CcSEcCtD
Tolmetin—Visual impairment—Methotrexate—esophageal cancer	8.82e-05	0.00797	CcSEcCtD
Tolmetin—Oedema—Capecitabine—esophageal cancer	8.74e-05	0.0079	CcSEcCtD
Tolmetin—Erythema multiforme—Methotrexate—esophageal cancer	8.66e-05	0.00782	CcSEcCtD
Tolmetin—Thrombocytopenia—Capecitabine—esophageal cancer	8.56e-05	0.00773	CcSEcCtD
Tolmetin—Tinnitus—Methotrexate—esophageal cancer	8.54e-05	0.00771	CcSEcCtD
Tolmetin—Asthenia—Cisplatin—esophageal cancer	8.51e-05	0.00769	CcSEcCtD
Tolmetin—TDO2—Metabolism—PTGS1—esophageal cancer	8.43e-05	0.000984	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—GHRL—esophageal cancer	8.42e-05	0.000983	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—RB1—esophageal cancer	8.41e-05	0.000982	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.33e-05	0.000972	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.33e-05	0.000972	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PSME1—esophageal cancer	8.31e-05	0.00097	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PSME2—esophageal cancer	8.31e-05	0.00097	CbGpPWpGaD
Tolmetin—Diarrhoea—Cisplatin—esophageal cancer	8.11e-05	0.00733	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	8.1e-05	0.000945	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	7.93e-05	0.000925	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—HIF1A—esophageal cancer	7.81e-05	0.000912	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	7.7e-05	0.000899	CbGpPWpGaD
Tolmetin—Dyspepsia—Capecitabine—esophageal cancer	7.69e-05	0.00695	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	7.59e-05	0.000886	CbGpPWpGaD
Tolmetin—Vomiting—Cisplatin—esophageal cancer	7.54e-05	0.00681	CcSEcCtD
Tolmetin—Constipation—Capecitabine—esophageal cancer	7.47e-05	0.00675	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—CDKN2A—esophageal cancer	7.4e-05	0.000863	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MYC—esophageal cancer	7.21e-05	0.000842	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP1B1—esophageal cancer	7.17e-05	0.000837	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Capecitabine—esophageal cancer	7.15e-05	0.00646	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—esophageal cancer	7.06e-05	0.000824	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKAP13—esophageal cancer	7.05e-05	0.000823	CbGpPWpGaD
Tolmetin—Nausea—Cisplatin—esophageal cancer	7.04e-05	0.00636	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—CREBBP—esophageal cancer	6.99e-05	0.000816	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—esophageal cancer	6.94e-05	0.000811	CbGpPWpGaD
Tolmetin—Urticaria—Capecitabine—esophageal cancer	6.94e-05	0.00627	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	6.94e-05	0.00081	CbGpPWpGaD
Tolmetin—Body temperature increased—Capecitabine—esophageal cancer	6.91e-05	0.00624	CcSEcCtD
Tolmetin—Abdominal pain—Capecitabine—esophageal cancer	6.91e-05	0.00624	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	6.9e-05	0.000806	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ACTB—esophageal cancer	6.88e-05	0.000804	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—PIK3CA—esophageal cancer	6.88e-05	0.000803	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	6.86e-05	0.000801	CbGpPWpGaD
Tolmetin—Chest pain—Methotrexate—esophageal cancer	6.79e-05	0.00613	CcSEcCtD
Tolmetin—TDO2—Metabolism—CYP19A1—esophageal cancer	6.74e-05	0.000787	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	6.71e-05	0.000784	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EP300—esophageal cancer	6.62e-05	0.000773	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	6.6e-05	0.000771	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KMT2D—esophageal cancer	6.58e-05	0.000768	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	6.57e-05	0.000767	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Methotrexate—esophageal cancer	6.51e-05	0.00588	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—esophageal cancer	6.5e-05	0.000759	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PDE4D—esophageal cancer	6.45e-05	0.000753	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKAP13—esophageal cancer	6.4e-05	0.000747	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CREBBP—esophageal cancer	6.38e-05	0.000745	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Methotrexate—esophageal cancer	6.37e-05	0.00576	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—RB1—esophageal cancer	6.36e-05	0.000742	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.31e-05	0.000737	CbGpPWpGaD
Tolmetin—Asthenia—Capecitabine—esophageal cancer	6.27e-05	0.00567	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	6.23e-05	0.000728	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—HSPA5—esophageal cancer	6.22e-05	0.000726	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—HMOX1—esophageal cancer	6.15e-05	0.000718	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GNG7—esophageal cancer	6.13e-05	0.000716	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	6.12e-05	0.000714	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1A—esophageal cancer	6.04e-05	0.000706	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CALR—esophageal cancer	6.03e-05	0.000704	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	6.02e-05	0.000703	CbGpPWpGaD
Tolmetin—Diarrhoea—Capecitabine—esophageal cancer	5.98e-05	0.0054	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	5.93e-05	0.000692	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—GHRL—esophageal cancer	5.93e-05	0.000692	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—esophageal cancer	5.92e-05	0.000691	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ABCB1—esophageal cancer	5.91e-05	0.000689	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	5.87e-05	0.000686	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADCYAP1—esophageal cancer	5.87e-05	0.000685	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PDE4D—esophageal cancer	5.85e-05	0.000683	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—FBXW7—esophageal cancer	5.83e-05	0.000681	CbGpPWpGaD
Tolmetin—Somnolence—Methotrexate—esophageal cancer	5.78e-05	0.00523	CcSEcCtD
Tolmetin—Dizziness—Capecitabine—esophageal cancer	5.78e-05	0.00522	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.73e-05	0.000668	CbGpPWpGaD
Tolmetin—Dyspepsia—Methotrexate—esophageal cancer	5.73e-05	0.00517	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	5.6e-05	0.000653	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—esophageal cancer	5.59e-05	0.000652	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNG7—esophageal cancer	5.57e-05	0.00065	CbGpPWpGaD
Tolmetin—Vomiting—Capecitabine—esophageal cancer	5.56e-05	0.00502	CcSEcCtD
Tolmetin—Headache—Capecitabine—esophageal cancer	5.47e-05	0.00495	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	5.42e-05	0.000633	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	5.42e-05	0.000633	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL2—esophageal cancer	5.4e-05	0.000631	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—esophageal cancer	5.37e-05	0.000627	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—WWOX—esophageal cancer	5.37e-05	0.000626	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Methotrexate—esophageal cancer	5.32e-05	0.00481	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	5.3e-05	0.000619	CbGpPWpGaD
Tolmetin—Nausea—Capecitabine—esophageal cancer	5.19e-05	0.00469	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	5.17e-05	0.000604	CbGpPWpGaD
Tolmetin—Urticaria—Methotrexate—esophageal cancer	5.17e-05	0.00467	CcSEcCtD
Tolmetin—Abdominal pain—Methotrexate—esophageal cancer	5.14e-05	0.00465	CcSEcCtD
Tolmetin—Body temperature increased—Methotrexate—esophageal cancer	5.14e-05	0.00465	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	5.13e-05	0.000598	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.12e-05	0.000598	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FKBP1A—esophageal cancer	5.1e-05	0.000596	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ANXA1—esophageal cancer	5.02e-05	0.000586	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	5e-05	0.000584	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—WIF1—esophageal cancer	4.99e-05	0.000582	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL2—esophageal cancer	4.91e-05	0.000573	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—SST—esophageal cancer	4.89e-05	0.00057	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GHRL—esophageal cancer	4.76e-05	0.000556	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	4.76e-05	0.000556	CbGpPWpGaD
Tolmetin—Asthenia—Methotrexate—esophageal cancer	4.67e-05	0.00422	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.66e-05	0.000544	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CSNK1A1—esophageal cancer	4.6e-05	0.000537	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1A—esophageal cancer	4.57e-05	0.000533	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ANXA1—esophageal cancer	4.56e-05	0.000532	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC52A3—esophageal cancer	4.55e-05	0.000532	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BLVRB—esophageal cancer	4.55e-05	0.000532	CbGpPWpGaD
Tolmetin—Diarrhoea—Methotrexate—esophageal cancer	4.45e-05	0.00402	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—SST—esophageal cancer	4.44e-05	0.000518	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EP300—esophageal cancer	4.35e-05	0.000507	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GHRL—esophageal cancer	4.32e-05	0.000505	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC52A3—esophageal cancer	4.32e-05	0.000504	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PFN1—esophageal cancer	4.31e-05	0.000503	CbGpPWpGaD
Tolmetin—Dizziness—Methotrexate—esophageal cancer	4.3e-05	0.00389	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	4.15e-05	0.000484	CbGpPWpGaD
Tolmetin—Vomiting—Methotrexate—esophageal cancer	4.14e-05	0.00374	CcSEcCtD
Tolmetin—PTGS2—Disease—KMT2D—esophageal cancer	4.12e-05	0.000481	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—esophageal cancer	4.12e-05	0.00048	CbGpPWpGaD
Tolmetin—Headache—Methotrexate—esophageal cancer	4.08e-05	0.00368	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.07e-05	0.000475	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CREBBP—esophageal cancer	3.95e-05	0.000461	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	3.94e-05	0.00046	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA1—esophageal cancer	3.87e-05	0.000452	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC10A2—esophageal cancer	3.87e-05	0.000452	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ELMO1—esophageal cancer	3.87e-05	0.000452	CbGpPWpGaD
Tolmetin—Nausea—Methotrexate—esophageal cancer	3.86e-05	0.00349	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—AKAP13—esophageal cancer	3.78e-05	0.000441	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	3.64e-05	0.000425	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	3.62e-05	0.000423	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BLVRB—esophageal cancer	3.62e-05	0.000422	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC52A3—esophageal cancer	3.62e-05	0.000422	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA2—esophageal cancer	3.54e-05	0.000413	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NOS3—esophageal cancer	3.53e-05	0.000412	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIST1H2BM—esophageal cancer	3.49e-05	0.000407	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.49e-05	0.000407	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.46e-05	0.000404	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDE4D—esophageal cancer	3.46e-05	0.000404	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.35e-05	0.000391	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PLCE1—esophageal cancer	3.29e-05	0.000384	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ADH7—esophageal cancer	3.29e-05	0.000384	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNG7—esophageal cancer	3.29e-05	0.000384	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.25e-05	0.00038	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—esophageal cancer	3.23e-05	0.000377	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.23e-05	0.000377	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FKBP1A—esophageal cancer	3.19e-05	0.000373	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	3.16e-05	0.000369	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.12e-05	0.000364	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DOCK2—esophageal cancer	3.12e-05	0.000364	CbGpPWpGaD
Tolmetin—PTGS2—Disease—WIF1—esophageal cancer	3.12e-05	0.000364	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—esophageal cancer	3.11e-05	0.000363	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	3.09e-05	0.000361	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—XIAP—esophageal cancer	3.08e-05	0.00036	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA1—esophageal cancer	3.07e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC10A2—esophageal cancer	3.07e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.03e-05	0.000354	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNA1—esophageal cancer	2.91e-05	0.00034	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL2—esophageal cancer	2.9e-05	0.000338	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ADH1B—esophageal cancer	2.89e-05	0.000337	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CSNK1A1—esophageal cancer	2.88e-05	0.000336	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA2—esophageal cancer	2.81e-05	0.000328	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMP—esophageal cancer	2.76e-05	0.000322	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.75e-05	0.000321	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSME1—esophageal cancer	2.71e-05	0.000316	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSME2—esophageal cancer	2.71e-05	0.000316	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ANXA1—esophageal cancer	2.69e-05	0.000315	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—EP300—esophageal cancer	2.69e-05	0.000314	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP26A1—esophageal cancer	2.68e-05	0.000313	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.68e-05	0.000313	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SST—esophageal cancer	2.62e-05	0.000306	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALOX15—esophageal cancer	2.62e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADH7—esophageal cancer	2.61e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PLCE1—esophageal cancer	2.61e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	2.59e-05	0.000303	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.59e-05	0.000303	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.58e-05	0.000302	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GHRL—esophageal cancer	2.55e-05	0.000298	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH3—esophageal cancer	2.55e-05	0.000298	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FBXW7—esophageal cancer	2.51e-05	0.000293	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTO1—esophageal cancer	2.5e-05	0.000291	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TPI1—esophageal cancer	2.5e-05	0.000291	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.47e-05	0.000288	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ELMO1—esophageal cancer	2.42e-05	0.000282	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDOB—esophageal cancer	2.39e-05	0.000279	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TPI1—esophageal cancer	2.37e-05	0.000276	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GSTO1—esophageal cancer	2.37e-05	0.000276	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GAPDH—esophageal cancer	2.3e-05	0.000269	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADH1B—esophageal cancer	2.29e-05	0.000268	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH2—esophageal cancer	2.29e-05	0.000267	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CRABP1—esophageal cancer	2.28e-05	0.000266	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ALDOB—esophageal cancer	2.27e-05	0.000265	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.24e-05	0.000261	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMP—esophageal cancer	2.19e-05	0.000256	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GAPDH—esophageal cancer	2.18e-05	0.000255	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIST1H2BM—esophageal cancer	2.18e-05	0.000255	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GNG7—esophageal cancer	2.17e-05	0.000253	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.15e-05	0.000251	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP26A1—esophageal cancer	2.13e-05	0.000249	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.1e-05	0.000245	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALOX15—esophageal cancer	2.08e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDH2—esophageal cancer	2.03e-05	0.000237	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFBR2—esophageal cancer	2.03e-05	0.000237	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—esophageal cancer	1.99e-05	0.000232	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTO1—esophageal cancer	1.98e-05	0.000231	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TPI1—esophageal cancer	1.98e-05	0.000231	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—esophageal cancer	1.93e-05	0.000226	CbGpPWpGaD
Tolmetin—PTGS2—Disease—XIAP—esophageal cancer	1.93e-05	0.000225	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMAD4—esophageal cancer	1.92e-05	0.000225	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP2A6—esophageal cancer	1.91e-05	0.000223	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.91e-05	0.000222	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDOB—esophageal cancer	1.9e-05	0.000222	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GAPDH—esophageal cancer	1.83e-05	0.000213	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.82e-05	0.000213	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ENO1—esophageal cancer	1.81e-05	0.000212	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CRABP1—esophageal cancer	1.81e-05	0.000211	CbGpPWpGaD
Tolmetin—PTGS2—Disease—B2M—esophageal cancer	1.79e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSME2—esophageal cancer	1.79e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSME1—esophageal cancer	1.79e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.77e-05	0.000206	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GNG7—esophageal cancer	1.72e-05	0.000201	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ENO1—esophageal cancer	1.72e-05	0.000201	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSME2—esophageal cancer	1.69e-05	0.000198	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSME1—esophageal cancer	1.69e-05	0.000198	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CALR—esophageal cancer	1.63e-05	0.00019	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDH2—esophageal cancer	1.61e-05	0.000188	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIF1A—esophageal cancer	1.57e-05	0.000184	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FBXW7—esophageal cancer	1.57e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.56e-05	0.000182	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.54e-05	0.00018	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—esophageal cancer	1.54e-05	0.000179	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.52e-05	0.000177	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.51e-05	0.000177	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KDR—esophageal cancer	1.51e-05	0.000176	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.45e-05	0.000169	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTGS1—esophageal cancer	1.44e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ENO1—esophageal cancer	1.44e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSME2—esophageal cancer	1.42e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSME1—esophageal cancer	1.42e-05	0.000166	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH1—esophageal cancer	1.42e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMOX1—esophageal cancer	1.32e-05	0.000154	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.3e-05	0.000151	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CREBBP—esophageal cancer	1.29e-05	0.00015	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFBR2—esophageal cancer	1.27e-05	0.000148	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCB1—esophageal cancer	1.27e-05	0.000148	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—esophageal cancer	1.26e-05	0.000147	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.22e-05	0.000143	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—esophageal cancer	1.21e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMAD4—esophageal cancer	1.2e-05	0.00014	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—esophageal cancer	1.15e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.15e-05	0.000134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—esophageal cancer	1.1e-05	0.000128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—esophageal cancer	1.08e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMOX1—esophageal cancer	1.05e-05	0.000123	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.03e-05	0.00012	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCB1—esophageal cancer	1.01e-05	0.000118	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIF1A—esophageal cancer	9.85e-06	0.000115	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.6e-06	0.000112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—esophageal cancer	9.51e-06	0.000111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—esophageal cancer	9.2e-06	0.000107	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS2—esophageal cancer	8.96e-06	0.000105	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOTCH1—esophageal cancer	8.87e-06	0.000104	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—esophageal cancer	8.76e-06	0.000102	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CREBBP—esophageal cancer	8.48e-06	9.9e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CREBBP—esophageal cancer	8.04e-06	9.39e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—esophageal cancer	7.63e-06	8.91e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.62e-06	8.89e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—esophageal cancer	7.6e-06	8.87e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—esophageal cancer	7.46e-06	8.71e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—esophageal cancer	7.2e-06	8.41e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—esophageal cancer	6.95e-06	8.11e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CREBBP—esophageal cancer	6.74e-06	7.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—esophageal cancer	6.74e-06	7.86e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—esophageal cancer	6.48e-06	7.56e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—esophageal cancer	6.27e-06	7.31e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—esophageal cancer	6.03e-06	7.04e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—esophageal cancer	5.78e-06	6.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—esophageal cancer	5.76e-06	6.72e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—esophageal cancer	5.48e-06	6.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—esophageal cancer	4.77e-06	5.57e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—esophageal cancer	4.67e-06	5.45e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—esophageal cancer	4.59e-06	5.35e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—esophageal cancer	4.27e-06	4.99e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—esophageal cancer	4.05e-06	4.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—esophageal cancer	3.39e-06	3.96e-05	CbGpPWpGaD
